你的位置:在线配资炒股网站_10倍杠杆交易_正规官网平台 > 在线配资炒股网站 > 证券投资公司 上半年销量暴跌50%!Stellantis重申保留玛莎拉蒂!
证券投资公司 上半年销量暴跌50%!Stellantis重申保留玛莎拉蒂!
发布日期:2024-09-21 15:15 点击次数:192
今年1-6月,玛莎拉蒂的销量与去年同期相比暴跌了50%以上,仅为6,500辆,调整后的营业亏损8200万欧元。而Stellantis首席执行官卡Carlos Tavares也在此前表示:“如果他们不赚钱,我们就会关闭他们。我们不能承受不赚钱的品牌。”
另据Stellantis集团在7月30日发表声明表示,其仍致力于将玛莎拉蒂保留在其投资组合中里;并透露:“Stellantis重申了对玛莎拉蒂美好未来的坚定承诺,玛莎拉蒂是14个Stellantis品牌中独一无二的豪华品牌。”
另据海外媒体透露证券投资公司,玛莎拉蒂销量下滑多少有些令人意外,因为目前的GranTurismo与其替代车型相比有很大不同。而入门级Grecale SUV有望成为该品牌的畅销车型,并帮助其实现100,000辆的年销量;而Quattroporte和Ghibli轿车的换代工作也仍在缓慢的进行中。
","del":0,"gnid":"96c4ec33ba0195a9b","img_data":[{"flag":2,"img":[{"desc":"","height":"533","title":"","url":"http://p1.img.360kuai.com/t110df81bbccf9766893a9eceec.jpg","width":"800"},{"desc":"","height":"533","title":"","url":"http://p1.img.360kuai.com/t110df81bbcf033f085aac948cd.jpg","width":"800"},{"desc":"","height":"533","title":"","url":"http://p0.img.360kuai.com/t110df81bbc742c0f4ce189ae21.jpg","width":"800"},{"desc":"","height":"533","title":"","url":"http://p2.img.360kuai.com/t110df81bbcfe34a0a6d5f0944e.jpg","width":"800"},{"desc":"","height":"533","title":"","url":"http://p2.img.360kuai.com/t110df81bbc89f4898b1dca56e5.jpg","width":"800"}]}],"original":0,"pat":"art_src_3,fts0,sts0","powerby":"cache","pub_time":1722575160000,"pure":"","rawurl":"http://zm.news.so.com/f51529f3f09512e1a850a89f4543b9a6","redirect":0,"rptid":"ef0d19f3dc423958","rss_ext":[],"s":"t","src":"爱卡汽车","tag":[{"clk":"kcar_1:玛莎拉蒂","k":"玛莎拉蒂","u":""},{"clk":"kcar_1:ghibli","k":"ghibli","u":""}],"title":"上半年销量暴跌50%!Stellantis重申保留玛莎拉蒂!","type":"zmt","wapurl":"http://zm.news.so.com/f51529f3f09512e1a850a89f4543b9a6","ytag":"汽车:汽车行业","zmt":{"brand":{},"cert":"爱卡汽车官方账号","desc":"爱卡汽车是中国汽车社会化网络互动媒体平台。","fans_num":96516,"id":"2745652254","is_brand":"0","name":"爱卡汽车","new_verify":"5","pic":"https://p0.img.360kuai.com/t01f7f9800b64aa7f34.jpg","real":1,"textimg":"https://p9.img.360kuai.com/bl/0_3/t017c4d51e87f46986f.png","verify":"0"},"zmt_status":0}","errmsg":"","errno":0} 上一篇:在线配资平台 8月1日湘泵转债上涨2.03%,转股溢价率28.81%
下一篇:南昌股票配资 药企寻找新剂型开发新方案 新型制剂厂商三迭纪迎来合作热